Changes of QTc interval after opioid switching to oral methadone (Q44340756)

2 December 2017

Changes of QTc interval after opioid switching to oral methadone (English)

1 reference

2 December 2017

0 references

Claudio Adile

3

0 references

Alessandra Casuccio

object named as

Alessandra Casuccio

series ordinal

4

0 references

Sebastiano Mercadante

series ordinal

1

object named as

Sebastiano Mercadante

1 reference

2 December 2017

Giovanna Prestia

2

1 reference

2 December 2017

15 August 2013

1 reference

Supportive Care in Cancer

2 December 2017

1 reference

2 December 2017

21

1 reference

2 December 2017

3421-3424

1 reference

2 December 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-013-1928-y

2 December 2017

0 references

cites work

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Measurement of QTc in patients receiving chronic methadone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Methadone: to ECG or not to ECG...That is still the question

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

QTc interval prolongation associated with intravenous methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Torsade de pointes associated with very-high-dose methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Heterogeneous impact of methadone on the QTc interval: what are the practical implications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

QTc interval screening in methadone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

QTc interval prolongation in patients on long-term methadone maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

The impact of methadone induction on cardiac conduction in opiate users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Impact of methadone treatment on cardiac repolarization and conduction in opioid users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Opioid switching: a systematic and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1928-Y

Fluctuating QTc interval in an asymptomatic patient treated with methadone for chronic pain

21 January 2018

1 reference

12 December 2020

Methadone maintenance, QTc and torsade de pointes: Who needs an electrocardiogram and what is the prevalence of QTc prolongation?

1 reference

12 December 2020

Effects of methadone on QT-interval dispersion

1 reference

12 December 2020

First do no harm ... Reduction?

1 reference

12 December 2020

10.1007/S00520-013-1928-Y

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

23949740